Browsing Evidence Based Practice, 2011 (MU) by Title "What are the risks and benefits of long-acting anticholinergics in patients with asthma?"
Now showing items 1-1 of 1
(Family Physicians Inquiries Network, 2011-08)Long-acting anticholinergics (LAAchs) have been demonstrated to improve peak expiratory flow (PEF) and forced expiratory volume over 1 second (FEV1) in patients with asthma. (SOR: C, based on disease-oriented outcomes.) ...